NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
Sativa Group Plc
(“Sativa” or the “Company” or the “Group”)
Conditional CSE Approval of Sativa Wellness Group Inc
10 September 2020
The Company is pleased to announce that the Canadian Securities Exchange (“CSE”) conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously announced, Sativa shareholders voted 99% in favour of the merger, with Stillcanna shareholders voting 99.9% in favour, and the Court sanctioned the Scheme of Arrangement, subject to unconditional CSE approval. Unconditional approval and the resumption of trading on the CSE of Sativa Wellness Group Inc. is expected within the next 12 days, with a quotation on the AQSE Growth Market expected around the same time.
The new Sativa Wellness officers are Henry Lees-Buckley as Chief Executive Officer, Joseph Colliver as Chief Financial Officer, both Board Directors, and Anne Tew as Corporate Secretary. The Board of Directors will also include Jonathan Wearing as Chairman, and Angus Kerr, Mark Blower and Jason Dussault as Directors. Jason will additionally be leading our Investor Relations efforts.
A new corporate website that will be AQSE Growth Market Rule 71 compliant on admission, has been launched for shareholders and investors to gain further information. Please go online to sativawellnessgroup.com. The new trading symbol, (ticker), will be “SWEL” for the Sativa Wellness trading on the CSE and AQSE.
The newly released corporate video, housed on our new Sativa Wellness Group YouTube channel, explains how we have created a fully integrated European seed to consumer offering. By having the stewardship of the product through the entire supply chain it will allow us to not only deliver consistent quality to our consumers, but also CBD you can trust from the ability to be fully compliant with all UK industry regulations such as the FSA Novel Foods Accreditation.
The directors of the Company accept responsibility for the contents of this announcement.
Guy Miller/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7220 9795